Shanghai Junshi Biosciences (1877) Completes 2026 First Tranche Technology Innovation Bonds Issuance

Bulletin Express01-26

Shanghai Junshi Biosciences Co., Ltd. (Stock code: 1877) announced the completion of its 2026 first tranche of technology innovation bonds. According to the announcement, the company issued RMB1 billion in bonds with a 3+2-year term, maturing on 26 January 2031, and carrying an issuance interest rate of 2.70%.

The board of directors noted that Shanghai Junshi Biosciences received the funds on 26 January 2026 following acceptance of registration for the medium term notes by the national association of financial market institutional investors. The announcement advises shareholders and potential investors to exercise caution when dealing in the company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment